Camurus mail
Camurus is a Swedish biotech company that develops and commercializes innovative, long-acting injectable treatments for patients with severe and debilitating diseases.
Camurus' main product is the proprietary drug delivery technology called FluidCrystal, which allows for the development of long-acting injectable formulations of existing drugs. This technology enables the creation of injectable products that can provide sustained release of the active pharmaceutical ingredient over a period of several weeks or months, reducing the need for frequent injections and improving patient compliance.
Camurus has developed several products using the FluidCrystal technology, including:
- Aziyo Biologics' CryoScalp: a long-acting injectable treatment for psoriasis and other skin conditions.
- Camurus' own product, Camurus' Long-Acting Buprenorphine: a long-acting injectable treatment for opioid use disorder.
- Camurus' Long-Acting Olanzapine: a long-acting injectable treatment for schizophrenia and bipolar disorder.
Camurus' products are designed to provide improved patient outcomes, increased treatment adherence, and reduced healthcare costs. The company is working with pharmaceutical companies and research institutions to develop new products and expand its pipeline.
If you are looking for more information on Camurus or its products, I recommend visiting their website or contacting their customer service department.